ArticleInternational journal of chronic obstructive pulmonary disease2017
Measures of bronchodilator response of FEV
Article in International journal of chronic obstructive pulmonary disease, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 14 citations in OpenAlex.
- Assessment of Bronchodilator Responsiveness and Spirometric Patterns in Patients with Rhinitis and Suspected Asthma.Journal of asthma and allergy · 2026Article
- Assessment of Bronchodilator Response in Patients with CF and Non-CF Bronchiectasis-A Randomized Controlled Study.Journal of clinical medicine · 2025Article
- Bronchodilator Response in Post-COVID-19 Patients Undergoing Pulmonary Rehabilitation.Respiration; international review of thoracic diseases · 2024Article
- Effect of Smoking on Lung Function Decline in a Retrospective Study of a Health Examination Population in Chinese Males.Frontiers in medicine · 2022Article
- Clinical value of bronchodilator response for diagnosing asthma in steroid-naïve adults.ERJ open research · 2021Article
- Bronchodilator reversibility as a diagnostic test for adult asthma: findings from the population-based Tasmanian Longitudinal Health Study.ERJ open research · 2021Article
- Effects of treatment with long-acting muscarinic antagonists (LAMA) and long-acting beta-agonists (LABA) on lung function improvement in patients with bronchiectasis: an observational study.Journal of thoracic disease · 2021Article
- Clinical Significance of Bronchodilator Responsiveness Evaluated by Forced Vital Capacity in COPD: SPIROMICS Cohort Analysis.International journal of chronic obstructive pulmonary disease · 2019Observational
- COPD in exclusive narghile smokers: Some points to verify.Chronic respiratory disease · 2017Article
- Promoting the inclusion of vital-capacity data in the bronchodilator response.International journal of chronic obstructive pulmonary disease · 2017Article
- Occupational exposure to vapor, gas, dust, or fumes and chronic airflow limitation, COPD, and emphysema: the Swedish CArdioPulmonary BioImage Study (SCAPIS pilot).International journal of chronic obstructive pulmonary disease · 2017Article
- Validity of physician-diagnosed COPD in relation to spirometric definitions of COPD in a general population aged 50-64 years - the SCAPIS pilot study.International journal of chronic obstructive pulmonary disease · 2017Article
Corrections and comments
- Commented on by
Authors and funding
13 authors at 8 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundData are lacking from general population studies on how to define changes in lung function after bronchodilation. This study aimed to analyze different measures of bronchodilator response of forced expiratory volume in 1 second (FEV MATERIALS AND
methodsData were derived from the Swedish Cardiopulmonary Bioimage Study (SCAPIS) Pilot study. This analysis comprised 1,050 participants aged 50-64 years from the general population. Participants were investigated using a questionnaire, and FEV
resultsAmong all subjects, the greatest bronchodilator responses (FEV
conclusionWhen the bronchodilator response in asymptomatic never-smokers is reported as the difference in units of predicted normal, significant reversibility of FEV
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.